Yhb Investment Advisors, Inc. Biogen Inc. Transaction History

Yhb Investment Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 26, 2024	BUY	$212.02 - $267.71 $22,898 - $28,912	108 New	108 $23,000
Q1 2019 Apr 29, 2019	SELL	$216.71 - $338.96 $167,300 - $261,677	-772 Closed	0 $0
Q4 2018 Jan 11, 2019	SELL	$278.5 - $352.75 $12,532 - $15,873	-45 Reduced 5.51%	772 $232,000
Q3 2018 Oct 29, 2018	SELL	$293.51 - $383.83 $1,467 - $1,919	-5 Reduced 0.61%	817 $289,000
Q2 2018 Jul 09, 2018	SELL	$257.52 - $306.91 $12,876 - $15,345	-50 Reduced 5.73%	822 $239,000
Q1 2018 Apr 16, 2018	BUY	$260.13 - $367.91 $11,705 - $16,555	45 Added 5.44%	872 $239,000
Q4 2017 Jan 16, 2018	SELL	$307.64 - $344.58 $21,534 - $24,120	-70 Reduced 7.8%	827 $263,000
Q3 2017 Nov 06, 2017	BUY	$281.15 - $329.69 $252,191 - $295,731	897	897 $281,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Yhb Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Yhb Investment Advisors, Inc. with notifications on news.